 SOUTH SAN FRANCISCO, Calif., June 01, 2022 GLOBE NEWSWIRE -- Akero Therapeutics, Inc. Nasdaq: AKRO, a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at the Jefferies Global Healthcare Conference on Thursday, June 9, 2022, at 4:00 p.m. E.T. 